These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 25712373)

  • 1. MicroRNA-335 represents an independent prognostic marker in cervical cancer.
    Wang C; Jiang T
    Tumour Biol; 2015 Aug; 36(8):5825-30. PubMed ID: 25712373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant expression of microRNA-26b and its prognostic potential in human cervical cancer.
    Luo M; Shen D; Wang W; Xian J
    Int J Clin Exp Pathol; 2015; 8(5):5542-8. PubMed ID: 26191262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicoRNA-425-5p is a potential prognostic biomarker for cervical cancer.
    Sun L; Jiang R; Li J; Wang B; Ma C; Lv Y; Mu N
    Ann Clin Biochem; 2017 Jan; 54(1):127-133. PubMed ID: 27166306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased expression of microRNA-126 is associated with poor prognosis in patients with cervical cancer.
    Yang Y; Song KL; Chang H; Chen L
    Diagn Pathol; 2014 Dec; 9():220. PubMed ID: 25551621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced expression of miR-503 is associated with poor prognosis in cervical cancer.
    Yin ZL; Wang YL; Ge SF; Guo TT; Wang L; Zheng XM; Liu J
    Eur Rev Med Pharmacol Sci; 2015 Nov; 19(21):4081-5. PubMed ID: 26592830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. microRNA-944 overexpression is a biomarker for poor prognosis of advanced cervical cancer.
    Park S; Kim J; Eom K; Oh S; Kim S; Kim G; Ahn S; Park KH; Chung D; Lee H
    BMC Cancer; 2019 May; 19(1):419. PubMed ID: 31060525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of microRNA-142-3p in cervical cancer and its correlation with prognosis.
    Li M; Li BY; Xia H; Jiang LL
    Eur Rev Med Pharmacol Sci; 2017 May; 21(10):2346-2350. PubMed ID: 28617557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular identification of miR-145 and miR-9 expression level as prognostic biomarkers for early-stage cervical cancer detection.
    Azizmohammadi S; Safari A; Azizmohammadi S; Kaghazian M; Sadrkhanlo M; Yahaghi E; Farshgar R; Seifoleslami M
    QJM; 2017 Jan; 110(1):11-15. PubMed ID: 27345415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-148a represents an independent prognostic marker in bladder cancer.
    Ma L; Xu Z; Xu C; Jiang X
    Tumour Biol; 2016 Jun; 37(6):7915-20. PubMed ID: 26700670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance and functions of microRNA-93/CDKN1A axis in human cervical cancer.
    Zhang X; Li F; Zhu L
    Life Sci; 2018 Sep; 209():242-248. PubMed ID: 30098344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of miR-494 expression with tumor progression and patient survival in pancreatic cancer.
    Ma YB; Li GX; Hu JX; Liu X; Shi BM
    Genet Mol Res; 2015 Dec; 14(4):18153-9. PubMed ID: 26782462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-205 serves as a prognostic factor and suppresses proliferation and invasion by targeting insulin-like growth factor receptor 1 in human cervical cancer.
    Pang H; Yue X
    Tumour Biol; 2017 Jun; 39(6):1010428317701308. PubMed ID: 28651495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated expression of miR-24-3p is a potentially adverse prognostic factor in colorectal adenocarcinoma.
    Kerimis D; Kontos CK; Christodoulou S; Papadopoulos IN; Scorilas A
    Clin Biochem; 2017 Apr; 50(6):285-292. PubMed ID: 27939727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Up-regulated microRNA-155 expression is associated with poor prognosis in cervical cancer patients.
    Fang H; Shuang D; Yi Z; Sheng H; Liu Y
    Biomed Pharmacother; 2016 Oct; 83():64-69. PubMed ID: 27470551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-138 is a potential biomarker and tumor suppressor in human cervical carcinoma by reversely correlated with TCF3 gene.
    Li H; Sheng Y; Zhang Y; Gao N; Deng X; Sheng X
    Gynecol Oncol; 2017 Jun; 145(3):569-576. PubMed ID: 28385388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant TIMELESS expression is associated with poor clinical survival and lymph node metastasis in early-stage cervical carcinoma.
    Zhang W; He W; Shi Y; Zhao J; Liu S; Zhang F; Yang J; Xie C; Zhang Y
    Int J Oncol; 2017 Jan; 50(1):173-184. PubMed ID: 27909716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA 211 expression is upregulated and associated with poor prognosis in colorectal cancer: a case-control study.
    Sümbül AT; Göğebakan B; Bayram S; Batmacı CY; Öztuzcu S
    Tumour Biol; 2015 Dec; 36(12):9703-9. PubMed ID: 26152286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down-regulated MicroRNA 148b expression as predictive biomarker and its prognostic significance associated with clinicopathological features in non-small-cell lung cancer patients.
    Ghasemkhani N; Shadvar S; Masoudi Y; Talaei AJ; Yahaghi E; Goudarzi PK; Shakiba E
    Diagn Pathol; 2015 Sep; 10():164. PubMed ID: 26377406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased expression of microRNA-124 is an independent unfavorable prognostic factor for patients with breast cancer.
    Dong LL; Chen LM; Wang WM; Zhang LM
    Diagn Pathol; 2015 Apr; 10():45. PubMed ID: 25924779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased expression of microRNA-107 predicts poorer prognosis in glioma.
    Ji Y; Wei Y; Wang J; Ao Q; Gong K; Zuo H
    Tumour Biol; 2015 Jun; 36(6):4461-6. PubMed ID: 25596705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.